U.S. drug regulators have approved a drug aimed at preventing a respiratory disease in babies and toddlers. The U.S. Food and Drug Administration (FDA) on July 17 cleared Beyfortus, a monoclonal antibody that prevents respiratory syncytial virus (RSV), a lower ...